Sackler-owned opioid maker pushes overdose treatment abroad

Sackler-owned opioid maker pushes overdose treatment abroad
This Dec. 12, 2019, photo shows a sign at the Mundipharma International headquarters at Cambridge Science Park in England. Mundipharma is the international affiliate of Purdue Pharma, the maker of the blockbuster painkiller OxyContin. Mundipharma is now marketing Nyxoid, a new brand of naloxone, an opioid overdose reversal medication. (Source: AP Photo/Leila Coker/AP)

(AP) - The same pharmaceutical empire that manufactured the blockbuster opioid widely blamed for fueling the American epidemic is now selling an antidote for opioid overdoses through its international affiliate.

Mundipharma is owned by the billionaire Sackler family, which also owns OxyContin maker Purdue Pharma.

The company is now pushing abroad a strategy that U.S. court documents allege Purdue once considered in the U.S.

It is entering the market for opioid overdose treatment.

Mundipharma is selling an overdose reversal nasal spray from Europe to Australia.

The company has defended the drug as a lifesaving tool and says its sales strategies are separate from Purdue’s.

Copyright 2019 Associated Press. All rights reserved.